Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2022

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 110

Report ID: 118642


This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
GlaxoSmithKline
Salix Pharmaceuticals
Mpax Laboratories
Teva Pharmaceutical Industries
Novartis AG
Orion Corporation
Mylan NV
Par Pharmaceutical
Cipla
Daiichi Sankyo
Apotex
Wockhardt Limited
GSK
Novartis
Boehringer Ingelheim
Abbvie
Merck
Akorn
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F Hoffmann-La Roche
H Lundbeck
Kyowa Hakko Kirin Pharma
Stada Arzneimittel
Valeant
Apokyn

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Parkinson's Disease Therapeutics can be split into
Medications Therapeutics
Medical Devices Therapeutics

Market segment by Application, Parkinson's Disease Therapeutics can be split into
Hospitals
Clinics
Homecare Settings
Other


Table of Contents

Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Parkinson's Disease Therapeutics
1.1 Parkinson's Disease Therapeutics Market Overview
1.1.1 Parkinson's Disease Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Parkinson's Disease Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Parkinson's Disease Therapeutics Market by Type
1.3.1 Medications Therapeutics
1.3.2 Medical Devices Therapeutics
1.4 Parkinson's Disease Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Homecare Settings
1.4.4 Other

2 Global Parkinson's Disease Therapeutics Competition Analysis by Players
2.1 Parkinson's Disease Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 GlaxoSmithKline
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Salix Pharmaceuticals
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Mpax Laboratories
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Teva Pharmaceutical Industries
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Orion Corporation
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Mylan NV
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Par Pharmaceutical
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Cipla
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Daiichi Sankyo
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Parkinson's Disease Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Apotex
3.12 Wockhardt Limited
3.13 GSK
3.14 Novartis
3.15 Boehringer Ingelheim
3.16 Abbvie
3.17 Merck
3.18 Akorn
3.19 Astellas Pharma
3.20 Desitin Arzneimittel
3.21 Endo Pharmaceuticals
3.22 F Hoffmann-La Roche
3.23 H Lundbeck
3.24 Kyowa Hakko Kirin Pharma
3.25 Stada Arzneimittel
3.26 Valeant
3.27 Apokyn

4 Global Parkinson's Disease Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Parkinson's Disease Therapeutics Market Size by Type (2012-2017)
4.2 Global Parkinson's Disease Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Parkinson's Disease Therapeutics in Future
4.4 Top Consumer/End Users of Parkinson's Disease Therapeutics

5 United States Parkinson's Disease Therapeutics Development Status and Outlook
5.1 United States Parkinson's Disease Therapeutics Market Size (2012-2017)
5.2 United States Parkinson's Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Parkinson's Disease Therapeutics Development Status and Outlook
6.1 EU Parkinson's Disease Therapeutics Market Size (2012-2017)
6.2 EU Parkinson's Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Parkinson's Disease Therapeutics Development Status and Outlook
7.1 Japan Parkinson's Disease Therapeutics Market Size (2012-2017)
7.2 Japan Parkinson's Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Parkinson's Disease Therapeutics Development Status and Outlook
8.1 China Parkinson's Disease Therapeutics Market Size (2012-2017)
8.2 China Parkinson's Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Parkinson's Disease Therapeutics Development Status and Outlook
9.1 India Parkinson's Disease Therapeutics Market Size (2012-2017)
9.2 India Parkinson's Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Parkinson's Disease Therapeutics Development Status and Outlook
10.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Parkinson's Disease Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Parkinson's Disease Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Parkinson's Disease Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Parkinson's Disease Therapeutics Market Size by Application (2017-2022)

12 Parkinson's Disease Therapeutics Market Dynamics
12.1 Parkinson's Disease Therapeutics Market Opportunities
12.2 Parkinson's Disease Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Parkinson's Disease Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Parkinson's Disease Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source